NCT06560450

Brief Summary

The goal of this clinical study is to investigate the short-term impact of the use of Ceriter Stride One on the quality of gait in patients rehabilitating after a cerebrovascular accident (CVA). Stride One is a smart insole that provides real-time audio feedback (cues) to the patient when performing a certain exercise. The main questions it aims to answer are:

  • Will patients with a CVA show a qualitatively better gait pattern after training with a Stride One insole?
  • Can patients maintain this improvement in gait pattern without audio feedback at the end of the training? Participants will
  • Receive daily gait rehabilitation using Stride One for 1 week
  • The quality of the gait pattern was evaluated at the beginning and at the end of the week, with and without the use of Stride One
  • An additional evaluation was performed three to four days after the end of therapy without the use of Stride One
  • Immediately after the end of the intervention week, the patient and the treating therapist were asked about their findings regarding the use of Stride One while walking

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 19, 2024

Completed
Last Updated

August 19, 2024

Status Verified

August 1, 2024

Enrollment Period

4 months

First QC Date

August 8, 2024

Last Update Submit

August 16, 2024

Conditions

Keywords

CVA (Cerebrovascular Accident)Gait rehabilitationGait analysisTele-rehabilitation

Outcome Measures

Primary Outcomes (2)

  • Complete and correct foot roll-off

    The first primary endpoint of the study is the complete and correct foot roll-off (detected and interpreted in the Ceriter platform). Stride One provides auditory feedback to the patient, stimulating the patient to achieve a good roll-off of the foot. For each step it measures whether a correct heel-strike, mid-stance and terminal stance are achieved. The aim of Stride One is to teach patients to place their feet correctly, in order to obtain a better roll- off, using positive audio feedback.

    1 week while daily therapy was given

  • Changed walking speed/greater number of steps per minute

    1 week while daily therapy was given

Secondary Outcomes (4)

  • Improved functional tests: 5x sit-to-stand (seconds)

    Before the start of the therapy, immediately after the end of the intervention period and 2 days after the end of the therapy

  • Improved functional tests: 3-minute walking test without audio feedback

    Before the start of the therapy, immediately after the end of the intervention period and 2 days after the end of the therapy

  • Improved functional tests: 3-minute walking test with audio feedback

    Before the start of the therapy and immediately after the end of the intervention period

  • Subjective experiences: questionnaires

    Post intervention, 2 days after end of the therapy

Study Arms (1)

Real-time audio feedback

OTHER

Physiotherapist-defined real-time audio feedback

Device: Stride One

Interventions

Stride One is a smart insole that provides real-time audio feedback (cues) to the patient when performing a certain exercise. The goal of Stride One is to allow patients to practice walking more intensively and with higher quality during rehabilitation.

Real-time audio feedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CVA, residentially admitted to the rehabilitation center in Herk-de-Stad, Belgium
  • Older than 18 years of age
  • Gait problems as a result of the CVA
  • Able to walk safely and independently (possibly with a walking aid)
  • Able to understand and sign an information and consent form

You may not qualify if:

  • Severe cognitive problems (attention) that make it difficult to understand instructions or follow feedback
  • Hearing problem

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Frame, Jessa Ziekenhuis

Hasselt, 3500, Belgium

Location

Related Publications (3)

  • Khoo IH, Marayong P, Krishnan V, Balagtas M, Rojas O, Leyba K. Real-time biofeedback device for gait rehabilitation of post-stroke patients. Biomed Eng Lett. 2017 Jun 7;7(4):287-298. doi: 10.1007/s13534-017-0036-1. eCollection 2017 Nov.

    PMID: 30603178BACKGROUND
  • Kwakkel G, Stinear C, Essers B, Munoz-Novoa M, Branscheidt M, Cabanas-Valdes R, Lakicevic S, Lampropoulou S, Luft AR, Marque P, Moore SA, Solomon JM, Swinnen E, Turolla A, Alt Murphy M, Verheyden G. Motor rehabilitation after stroke: European Stroke Organisation (ESO) consensus-based definition and guiding framework. Eur Stroke J. 2023 Dec;8(4):880-894. doi: 10.1177/23969873231191304. Epub 2023 Aug 7.

    PMID: 37548025BACKGROUND
  • Kim J, Jung S, Song C. The Effects of Auditory Feedback Gait Training Using Smart Insole on Stroke Patients. Brain Sci. 2021 Oct 21;11(11):1377. doi: 10.3390/brainsci11111377.

    PMID: 34827376BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Sarah Meyer

    Frame Jessa Ziekenhuis

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Ten patients were offered therapy using Stride One for one week. Several measurements are performed before the start of the therapy, immediately after the end of the intervention period and 2 days after the end of the therapy.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2024

First Posted

August 19, 2024

Study Start

December 18, 2023

Primary Completion

April 29, 2024

Study Completion

April 29, 2024

Last Updated

August 19, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations